IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Amary, M Fernanda, Bacsi, Krisztian, Maggiani, Francesca, Damato, Stephen, Halai, Dina, Berisha, Fitim, Pollock, Robin, O'Donnell, Paul +8 more·2011·The Journal of Pathology
DOI 10.1002/path.2913

Cited by (1,000)

Items 801–900 of 1,000

  1. Identification of New Inhibitors of Mutant Isocitrate Dehydrogenase 2 through Molecular Similarity-based Virtual Screening
    Lijun Yang, Stefan Pusch, Victoria Jennings, Tianfang Ma, Qihua Zhu, Yungen Xu, Andreas von Deimling, Xiaoming Zha · 2018 · Letters in Drug Design & Discovery
  2. Non-odontogenic Bone Pathology
    Hedley G. Coleman, Jos J. Hille, Willie F. P. van Heerden, Sonja C. Boy, Annabelle M. Mahar · 2019 · Springer eBooks
  3. Cancer Metabolism
    Natalya N. Pavlova, Craig B. Thompson · 2016 · Wiley eBooks
  4. Bone Implants (Bone Regeneration and Bone Cancer Treatments)
    Hangxiang Sun, Xingzhi Zhou, Yongxing Zhang, Lei Zhang, Xiaohua Yu, Zhaoming Ye, Cato T. Laurencin · 2022 · Wiley eBooks
  5. Cancer stem cells and clonal evolution in bone sarcomas
    René Rodrı́guez, Jiřı́ Hatina, Stefano Gambera, Sofía T. Menéndez, Javier Garcı́a-Castro · 2021 · Elsevier eBooks
  6. Juxtacortical Chondroma: A Rare Entity Involving the Phalanges
    Aditi Saini, S. Gautham Shankar, Pradeep Kumar Roul, Sonal Saran, Sudhir Saxena · 2022 · Scholars Journal of Medical Case Reports
  7. Malignant transformation of Ollier disease-related multiple glioma with IDH1 p.R132C mutation
    Gen Watanabe, Yu Fujii, Yoshiki Hanaoka, Miyuki Tanaka, Mai Iwaya, Tetsuyoshi Horiuchi · 2024 · Rinsho Shinkeigaku
  8. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications
    Paraskevi Xekouki, Vasiliki Venetsanaki, Georgios Kyriakopoulos, Krystallenia Alexandraki, Anna G. Angelousi, Gregory Kaltsas · 2024 · Endocrine Reviews
  9. Misdiagnosis of chordoma: A case report and a review of the literature
    Dong Li, Mengmeng Zhang, Ping Zhang, Tao Wang, Jiang Chen · 2025 · Oncology Letters
  10. Clinical insights into circulating free-DNA in patients with bone sarcomas and ewing sarcoma
    Veronica Aran, Amanda dos Santos Cavalcanti, Walter Meohas, Bruna Canteri Delocco, Jamila Alessandra Perini, Jesús Pino, Joäo Antônio Matheus Guimaräes, Vivaldo Moura‐Neto, Maria Eugênia Leite Duarte · 2025 · Clinics
  11. Jaw
    2025 · American Registry of PathologyArlington, Virginia eBooks
  12. BCOR ‐Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study
    Diego M. Montoya‐Cerrillo, Mark Gordon Evans, Andrew J. Elliott, Renzo J. C. Calderon-Anyosa, Jaylou Velez Torres, Elizabeth Anne Montgomery, Francis John Hornicek, Harry Thomas Temple, Brooke Crawford, Jonathan C. Trent et al. · 2025 · Genes Chromosomes and Cancer
  13. IDH enzyme inhibition in cancer therapy: mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma
    Anthony Josephine, Sekar Ashok Kumar, Sureka Varalakshmi, P. Rajendran · 2026 · 3 Biotech
  14. Therapeutic targeting of tricarboxylic acid cycle and oxidative phosphorylation: a critical analysis of metabolic interventions in cancer treatment
    Yawei Han, Yuhao Wei, Yuanting Xie, Mengzhu Zheng · 2026 · Biochemical Pharmacology
  15. Lipid Metabolic Reprogramming and Epigenetic Co-Dysregulation Across the Central Chondrosarcoma Grade Spectrum: A Multi-Cohort RNA-seq Study
    Batuhan Ayhan, Neslihan Dönmez, Zeliha Deniz Ayhan · 2026 · International Journal of Molecular Sciences
  16. Prognostic Role of TERT Mutations in Chondrosarcoma: Associations with Dedifferentiation, Survival, and IDH/TERT Co-Mutations
    Alyan Zafar, Daisy A. Ference, Brooke M. Crawford, Sergio José Torralbas Fitz, Francis John Hornicek, Harry Thomas Temple · 2026 · Cancers
  17. Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME
    Sara Cardoso, Baptiste Ameline, Sanne Venneker, Debora M. Meijer, Zeynep Betül Erdem, Dina Ruano, Brendy E. van den Akker, Anne‐Marie Cleton-Jansen, Jon Brugger, Inge H. Briaire‐de Bruijn et al. · 2026 · Genes Chromosomes and Cancer
  18. DNA Methylation Profiling in IDH‐Mutant Gliomas: Biological Evolution, Molecular Grading and Clinical Implementation
    Pietro Tralongo, Gabriele Ricciardi, Mariagiovanna Ballato, Vincenzo Fiorentino, Valeria Zuccalà, Giorgia Castellani, Quintino Giorgio D’Alessandris, Guido Fadda, Lucia Ricci‐Vitiani, Maria Caffo et al. · 2026 · Neuropathology and Applied Neurobiology
  19. Modern therapeutic approaches in cholangiocarcinoma: A narrative review of key biomarkers and clinical trials
    Augusto Almeida, Joao Lucas Lima Manzi, Camila Hoff, Haaris Kadri, Alan S. Livingstone, Ana Gleisner, Emily Baiyee Toegel, Richard David Schulick, Paulo Marcelo Hoff, Rodrigo Vianna et al. · 2026 · Translational Oncology
  20. Genetic Aspects of Bone Tumors
    Shamini Selvarajah, Maria Zieleńska, Jeremy Andrew Squire, Paul C. Park · 2010 · Elsevier eBooks
  21. Isocitrate Dehydrogenase (IDH) Mutation in Gliomas
    Charles Chesnelong · 2015 · Springer eBooks
  22. Targeted Therapy of IDH1-Mutated Tumors
    Owen Clark, Christian Grommes · 2016 · Springer eBooks
  23. Clinicopathological features and differential diagnosis of chondrogenic tumours
    Arjen H.G. Cleven, Judith V.M.G. Bovée · 2020 · Diagnostic histopathology
  24. Systemic Therapy for Chondrosarcoma
    Arun S. Singh, Jomjit Chantharasamee, Francis John Hornicek · 2021 · Springer eBooks
  25. Periosteal Chondroma of the Pelvis: An Uncommon Tumor in an Unusual Location
    Gautham Prabhakar, Ameesh N. Dev, Fatemeh Ghazanfari Amlashi, Rajiv Rajani · 2021 · Cureus
  26. Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma
    Chen‐Yueh Wen, Kuan‐Hao Tsui, Chiung‐Hung Chang, Yi‐Han Chiu, Shu‐Chuan Lin, Ching-Yu Chu, Chia‐Jung Li · 2022 · Journal of Oncology
  27. Chondrosarcoma
    Sergio Piña‐Oviedo, Jae Yoon Ro, Alberto G. Ayala, Yong-Koo Park · 2015 · Springer eBooks
  28. Cancer Metabolism
    Daniel Richard Wahl, Sriram Venneti · 2017 · Springer eBooks
  29. Radiation Therapy in Chondrosarcoma
    Adriana Ayestarán, Julieth Vivian Sarmiento Palma, Felipe Ángel Calvo · 2023 · Springer eBooks
  30. IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
    Marcelo Barbosa Ribeiro, Jerúsia Oliveira Ibiapina, ANDRÉ MATHIAS BAPTISTA, Olavo Pires de Camargo · 2023 · Acta Ortopédica Brasileira
  31. Resolving challenges in detection and quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC/MS
    Tyrone Dowdy, Mioara Larion · 2026 · Methods
  32. Single cell analysis of Idh mutant growth plates identifies cell populations responsible for longitudinal bone growth and enchondroma formation
    Vijitha Puviindran, Eijiro Shimada, Zeyu Huang, Xinyi Ma, Ga I Ban, Yu Xiang, Hongyuan Zhang, Jianhong Ou, Xiaolin Wei, Makoto Nakagawa et al. · 2024 · Scientific Reports
  33. Cartilage Forming Tumors of the Skeleton
    Julio Alexander Díaz-Pérez, Andrew Eric Rosenberg · 2024 · Advances in Anatomic Pathology
  34. C. elegans Cytoplasmic Isocitrate Dehydrogenase Neomorphic G98N and R133H Mutants Produce the Oncometabolite 2-Hydroxyglutarate
    Melissa Bouchard, Anne McAllister, Noah S. Bourlett, Chelsea Hoyt, Laurent Calcul, Katherine M. Walstrom · 2025 · International Journal of Molecular Sciences
  35. Basic science of musculoskeletal tumours
    Kenneth Samora Rankin · 2017 · Orthopaedics and Trauma
  36. Detection of IDH1 and IDH2 Mutation in Formalin-fixed Paraffin-embedded Gliomas Using Allele-specific COLD-PCR and Probe Melting Curve Analysis
    Qing Zhang, Kun Liu, Wensheng Yang, Wei Shao, Dan Liu, Haitao Lan, Tianhai Ji · 2018 · Applied immunohistochemistry & molecular morphology
  37. Applications of Molecular Testing to Differential Diagnosis
    Alexander J. Lazar · 2013 · Elsevier eBooks
  38. The epigenomic impact of methylation in metabolic dysfunction and cancer
    Cynthia A. Zahnow · 2019 · Elsevier eBooks
  39. Diagnostische Herausforderungen bei Knorpeltumoren
    Wolfgang Hartmann · 2019 · Der Orthopäde
  40. Tumors of the Sacrum: Pathologic Aspect
    Yi Yang, Wei Guo · 2020 · Springer eBooks
  41. Markers for bone sarcomas
    Matthias Tallegas, Anne Gomez‐Brouchet, Mélanie Legrand, Corinne Bouvier, Gonzague Du Bouexic De Pinieux · 2021 · Elsevier eBooks
  42. Chondrosarcoma
    Sergio Piña‐Oviedo, Jae Yoon Ro, Alberto G. Ayala · 2020 · Springer eBooks
  43. Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma
    Laura M. Warmke, Liang Cheng C, R. Matthew Sperling, Joyashree D. Sen, Thomas M. Ulbright · 2022 · Modern Pathology
  44. An intermediate phenotype in IDH related enchondromatosis spectrum
    Elif Yılmaz Güleç, Pauline Marzin, Céline Huber, Valérie Cormier‐Daire · 2023 · European Journal of Medical Genetics
  45. Primary bone tumors
    Edward F. McCarthy, Frank J. Frassica · 2014 · Cambridge University Press eBooks
  46. Tumors of bone
    Fredrik Mertens, Nils Mandahl · 2015
  47. Advanced conventional chondrosarcomas: Time to revisit treatments and clinical research for what is not an indolent disease
    Antoîne Italiano · 2014 · Cancer
  48. [The perception of anxiety and stress in day surgery: a comparison among patients, family members and nurses].
    Alvisa Palese, Antonella Burlon, Mariuccia Rizzato, Paolo Dritti, Debora Matuella, Luigi Conte · 2004 · PubMed
  49. Metabolic Plasticity of IDH1- Mutant Glioma Cell Lines Is Responsible for Low Sensitivity to Glutaminase Inhibition
    Victor Ruiz‐Rodado, Adrian Lita, Tyrone Dowdy, Orieta Celiku, Alejandra Cavazos Saldana, Herui Wang, Aiguo Li, Wei Zhang, Hua Song, Meili Zhang et al. · 2019 · SSRN Electronic Journal
  50. Discovery and Development of Ivosidenib (AG‐120: TIBSOVO ® )
    Zenon D. Konteatis, Zhihua Sui · 2021
  51. Mesenchymal and Non‐Epithelial Tumors of the Pelvis
    Eugenia Schwarzkopf, Patrick J. Boland · 2021
  52. Benign Cartilage Tumors
    2021 · American Registry of PathologyArlington, Virginia eBooks
  53. Animal Model Study of Epigenetic Inhibitors
    Aili Chen, Gang Huang · 2015 · Elsevier eBooks
  54. Molecular Testing in Bone and Soft Tissue Tumors
    Brendan Craig Dickson, Gino R. Somers, Rita A. Kandel · 2014 · Springer eBooks
  55. Aktueller Stand der Molekularpathologie von Knochentumoren
    V. Böhmer, G. Köhler · 2013 · Der Onkologe
  56. Mutations de gènes impliqués dans le métabolisme énergétique et cancer
    Constance Thibault, Anne‐Paule Gimenez‐Roqueplo · 2013 · ONCOLOGIE
  57. Condrosarcoma secundario: presentación de un caso
    Juan F. Frómeta Martínez, Alejandro ro Álvarez López, Daniel Rodolfo Montánchez Salamanca, Heberth González Corredor, Yenima de la Caridad García Lorenzo, Osbi Quintero Rodríguez · 2012 · Revista Archivo Médico de Camagüey
  58. The pathophysiology of primary bone tumors in young adults and children
    Ira J. Miller, Paul M. Kent, Joseph D Finney · 2013 · Current Problems in Cancer
  59. Growth hormone deficiency and multiple Enchondromatosis (Ollier disease) in a boy with short stature
    Veselin Boyadzhiev, Boyan Dobrev Balev, Violeta Iotova · 2014 · Scripta Scientifica Medica
  60. Mutations in IDH 1 and IDH 2 are not present in sporadic ovarian sex cord–stromal tumours
    Sarah J. Aitken, Nadège Presneau, Bhavisha Khatri, Adrienne Margaret Flanagan, Blaise Alexander Clarke, Wilson Glenn McCluggage · 2014 · Histopathology
  61. Contribution of Molecular Biology to the Classification of Low-Grade Diffuse Glioma
    Hiroko Ohgaki · 2013 · Springer eBooks
  62. Epigenetic basis for the oncogenic potential of IDH mutations
    Chao Lü · 2013
  63. Targeted Therapy in Solid Tumors: Sarcomas
    Anthony Paul Conley, Vinod Ravi, SHREYASKUMAR R. PATEL · 2015
  64. Preface to the column "Metabolism of Childhood Cancer".
    Dinesh Rakheja · 2015 · PubMed Central
  65. Congrès de l’association américaine de recherche contre le cancer — AACR 2016
    Cécile Vicier, Éléonore De Guillebon, A. Kieffer, Anthony Turpin, Clément Dumont, Audrey Bellesœur, Daniele Grazziotin Soares, Jean‐Pierre Lotz · 2016 · ONCOLOGIE
  66. Chondroma arising from the spinal dura mater at the thoracic level: A case report with molecular analysis
    Masaya Miyazaki, Keita Yashiro, Mishie Ann Tanino, Shinya Tanaka, Yasunori Fujioka · 2016 · Pathology - Research and Practice
  67. MicroRNA-183 upregulates HIF-1a by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells
    Hirotomo TanakaTakashi, Masamitsu NishiharaKatsu · 2013
  68. Biologie moléculaire dans le diagnostic des tumeurs des tissus mous et de l’os et apport au pronostic des sarcomes
    Sophie Le Guellec · 2016 · ONCOLOGIE
  69. Targeting Metabolic Survival Pathways in Lung Cancer via Combination Therapy
    Christian M. Metallo · 2014
  70. Targeting One-Carbon Metabolism in Breast Cancer
    Elizaveta Freinkman · 2014
  71. Cytogenetic and Molecular Genetic Alterations in Bone Tumors
    Suvi P. Savola, Tom Böhling, Sakari Knuutila · 2010 · Elsevier eBooks
  72. Molecular Pathogenesis of Bone Tumours
    Maria Anna Smolle, Johannes Haybaeck · 2017 · Springer eBooks
  73. Histopathology of Sacral Tumors and Pseudotumors
    Marilyn M. Bui, Yi Ding, Evita Henderson Jackson, Angelo Paolo Dei Tos · 2017 · Springer eBooks
  74. Novel Therapies and Future Directions in Treatment of Musculoskeletal Sarcomas
    Ratesh Khillan, Mohan Preet, Tanya DiFrancesco, Uchechi Uzoegwu, Osman Ali, Aditya V. Maheshwari · 2017 · Springer eBooks
  75. Benigne Tumoren und tumorähnliche Veränderungen (Tumor-like Lesions) I
    Adam Greenspan, Javier Beltran · 2017 · Elsevier eBooks
  76. Meningeal Mass Lesions
    Mahlon D. Johnson, Ali H Hussain · 2017 · Cambridge University Press eBooks
  77. Molecular Drivers in Chondrosarcoma
    Yvonne de Jong, Judith V.M.G. Bovée · 2017 · Elsevier eBooks
  78. Systemic Therapies for Locally Recurrent or Metastatic Disease
    Elizabeth J. Davis, Rashmi K Chugh, Scott M. Schuetze · 2017 · Elsevier eBooks
  79. Molecular testing of sarcomas
    Fernanda M Amary, Nischalan Pillay, Adrienne Margaret Flanagan · 2017 · Diagnostic histopathology
  80. Non-Odontogenic Bone Pathology
    Hedley G. Coleman, Jos J. Hille, Willie F. P. van Heerden, Sonja C. Boy, Annabelle M. Mahar · 2018 · Springer eBooks
  81. Benigne Tumoren und tumorähnliche Veränderungen (Tumor-like Lesions) II
    Adam Greenspan, Javier Beltran · 2017 · Elsevier eBooks
  82. Exploring Clinical and Biological Subtypes of Isocitrate Dehydrogenase Mutant Gliomas
    Romina Nejad · 2018 · TSpace (University of Toronto)
  83. Imaging Diagnosis and Treatment Progress of Metastatic Bone Tumor
    Rui Jiang, Ziyan Zhang, Han Wu, And Chao Zhang · 2018 · International Conference on Computer Science and Intelligent Communication (CSIC)
  84. Biology of Conventional Chondrosarcoma
    Maria Serena Benassi · 2019 · Springer eBooks
  85. Cytogenetic and molecular genetic alterations in bone tumors
    Tarja Niini, Sakari Knuutila · 2014 · Elsevier eBooks
  86. Genetic aspects of bone tumors
    Shamini Selvarajah, Paul C. Park, Maria Zieleńska, Jeremy Andrew Squire · 2014 · Elsevier eBooks
  87. Tumors of the Pelvis: Pathologic Aspect
    Matthew T. Houdek, Carrie Y. Inwards · 2020 · Springer eBooks
  88. Mutations de gènes impliqués dans le métabolisme énergétique et cancer Genetic mutations involved in energy metabolism and cancer
    Constance Thibault · 2013
  89. Quantitative analysis of 2-hydroxyglutarate as a controversial oncometabolite in malignant gliomas.
    Peter Bystrický, Ivana Kašubová, Romana Richterová, Zora Lasabová, Branislav Kolarovszki · 2020 · Neoplasma
  90. Exploring Immune Infiltration and Biomarkers of Ollier Chondrosarcoma
    Yuanlin Wang, Bing Li, Yiming Jia, Xiaolong Liu, Peihong Cao, Jun Liu · 2020
  91. Sarcomas óseos secundarios
    Jean-Camille Mattei, Anthony Michael Griffin, Peter Charles Ferguson, Geoffroy Venton, Jay Steven Wunder, Alexandre Rochwerger · 2020 · EMC - Aparato Locomotor
  92. Molecular Genetics in the Multidisciplinary Management of Sarcoma
    Vanessa Tran, John Slavin · 2020 · Springer eBooks
  93. The Role of Systemic Therapies in the Management of Bone Sarcoma
    Yat Hang To, Lisa M. Orme, Jeremy Howard Lewin · 2020 · Springer eBooks
  94. Bone Tumour Pathology
    Vanessa Tran, John Slavin · 2020 · Springer eBooks
  95. A Prognostic Model for the Overall Survival of Patients with Ewing's Sarcoma
    Xiaofei Feng, Yao Ma, Hai Lei, Wenji Wang · 2020 · Research Square
  96. Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression
    Kevin P. Kotredes · 2015 · TUScholarShare (Temple University)
  97. Chondrosarcomas: Conventional and Secondary
    Christopher M. Hart, Zachary D. C. Burke, Alex Nobori, Bennett L. Davis · 2021 · Springer eBooks
  98. Advances in the Molecular Biology of Chondrosarcoma
    Zhenfeng Duan, Dylan C. Dean, Susan V. Bukata, Francis John Hornicek · 2021 · Springer eBooks
  99. The Future of Chondrosarcoma Research and Treatment
    Pichaya Thanindratarn, Dylan C. Dean, Francis John Hornicek, Zhenfeng Duan · 2021 · Springer eBooks
  100. Mitochondrial metabolism and carcinogenesis
    Siddhesh Aras, Neeraja Purandare, Lawrence I. Grossman · 2021 · Elsevier eBooks